Ambu A/S
(OTC: AMBBY)
|
1:30 PM UTC, 07/01/24 | |||
---|---|---|---|---|
Last: $18.88 | Change: -0.12 | %Change: -0.63% | Volume: 100 |
Open: | $ 18.88 | Volume: | 100 | |
---|---|---|---|---|
High: | $ 18.88 | Yield(%) | 0.00 | |
Low: | $ 18.88 | P/E Ratio (ttm): | 98.08 | |
Dividend ($): | 0.02 | Market Cap ($): | 4.56B | |
EPS ($) | 0.20 | Shares Out: | 231.98M |
% Price Change (last 4 weeks): | 2.08 |
---|---|
% Price Change (last 13 weeks): | 22.28 |
% Price Change (last 26 weeks): | 26.03 |
% Price Change (last 52 weeks): | 22.46 |
% Price Change (year to date): | 26.11 |
Return on Equity (%): | 3.63 |
---|---|
Return on Assets (%): | 2.50 |
Return on Invested Capital (%): | 5.42 |
Gross Profit Margin (%): | 52.13 |
---|---|
Net Profit Margin (%): | 3.52 |
Operating Profit Margin (%): | 6.32 |
50-day Moving Average: | $9.18 |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | 450 |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $20.13 |
52-wk low: | $9.45 |
Bid: | $n/a |
Ask: | $n/a |
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
|
Ambu A/S
Baltorpbakken 13 Ballerup CR 2750 Phone: 45.72.25.20.00 Fax: 45.72.25.20.50 http://www.ambu.com |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | 98.08 |
Book Value ($): | 2.88 |
Cash Flow ($): | 0.31 |
Price/Earnings (x): | 98.08 |
---|---|
Price/Sales (x): | 4.00 |
Price/Book (x): | 3.65 |
Price/Cash Flow (x): | 36.84 |
Quick Ratio (x): | 1.17 |
---|---|
Current Ratio (x): | 2.13 |
LT Debt/Equity (x): | 9.49 |
Total Debt/Equity (x): | 10.83 |